Folks, if there’s one thing that boils my blood more than a liberal snowflake melting down over pronouns, it’s watching our so-called representatives in Congress treat the stock market like their personal piggy bank, especially when it comes to the health insurance racket that’s bleeding everyday Americans dry. These clowns are supposed to be fighting for us—cutting premiums, smashing bureaucracy, putting America First—but instead, they’re dipping their beaks into the very companies they oversee, trading stocks like it’s Vegas and the house always wins. And guess who foots the bill when they game the system? You do, with skyrocketing deductibles and denied claims. I’ve combed through the latest 2024 and 2025 financial disclosures, transaction reports, and ethics filings—the real deal, not some hack’s hot take—and what I found is a nest of vipers holding stakes in big health insurers like UnitedHealth (UNH), Elevance (ELV), and CVS Health (CVS). It’s not the whole swamp, but the ones who do? They’re betting your pain turns into their profit. Time to expose these grifters, tally their hauls, and demand we ban this crap before it bankrupts the republic.
The Ethics Charade: How Congress Hides Behind Blind Trusts and Bogus Rules
Every year, these 535 geniuses file annual financial disclosures by May 15, spilling their guts on assets worth over $1,000—stocks, bonds, the works—in vague ranges like $1,001 to $15,000 or $50,001 to $100,000. Then come the periodic transaction reports for any buy or sell over $1,000, due within 45 days. Sounds transparent? It’s a farce. Blind trusts that ain’t blind, spouses and kids holding the bag, and fines so puny they’re waived like parking tickets. In 2024 alone, members reported thousands of trades, often outperforming the market because, hey, who needs insider info when you’re writing the laws? Health insurance giants—UNH, ELV, Cigna (CI), Humana (HUM), Centene (CNC), Molina (MOH), CVS—are prime targets, raking in billions from Medicare, Medicaid, and Obamacare while denying care to pad profits. Owning their stock while voting on regs? That’s a conflict bigger than Biden’s ego. But fear not—I’ve drilled down to the direct owners and traders from the 2024-2025 filings. Spoiler: most hide in mutual funds, but the bold ones? They’re all in.
The UNH Grift: Betting Big on the Denial Machine
UnitedHealth’s the 800-pound gorilla, with tentacles in everything from Medicare Advantage to Optum’s data grabs. Their stock’s been a rollercoaster—down on hacks and probes, up on government handouts—but some pols couldn’t resist. Based on 2024-2025 transactions, these members held or traded UNH, implying ownership at some point. Sales spiked after DOJ probes in February and May 2025 exposed billing scams and care denials, with total dumps hitting up to $1.2 million against $950,000 in buys. Why sell? Maybe they saw the writing on the wall—or maybe they knew it first.
| Member | Chamber/Party/State | Stock | Approximate Value | Notes |
|---|---|---|---|---|
| Ro Khanna | House/D/CA | UNH | Up to $150,000 (collective with Cisneros and Shreve) | Sold in week after February 2025 DOJ civil probe report; held in family trusts. |
| Gilbert Cisneros | House/D/CA | UNH | Up to $150,000 (collective) | Sold in week after February 2025 report; managed by advisers. |
| Jefferson Shreve | House/R/IN | UNH | Up to $150,000 (collective) | Sold in week after February 2025 report; from charitable trust, now divesting individuals. |
| Jared Moskowitz | House/D/FL | UNH | Up to $45,000 | Sold day after May 2025 DOJ criminal probe report; some in kids’ names. |
| Julie Johnson | House/D/TX | UNH | Up to $30,000 | Sold between April and July 2025; divesting to avoid conflicts. |
| Greg Landsman | House/D/OH | UNH | Up to $50,000 | Sold in March 2025; spouse-owned, divesting. |
| David Taylor | House/R/OH | UNH | Up to $65,000 | Sold same day as May 2025 report. |
| Robert Bresnahan | House/R/PA | UNH | Up to $50,000 | Sold around day after May 2025 report. |
| Sheldon Whitehouse | Senate/D/RI | UNH | $15,001 – $50,000 | Sold in 2025; prior holding implied. |
| Marjorie Taylor Greene | House/R/GA | UNH | $1,001 – $15,000 | Purchased in 2025; likely current holding. |
| Tim Moore | House/R/NC | UNH | $1,001 – $15,000 | Purchased and sold in 2025; net zero or minimal holding. |
| John McGuire | House/R/VA | UNH | $1,001 – $15,000 | Purchased in 2025; stock tanked 45% post-buy. |
These values are from transaction ranges—actual holdings could be higher if unsold portions remain. Khanna and crew whine about blind trusts, but if you’re on Oversight, dumping stock amid probes smells fishy.
ELV and CVS: The Other Health Hustles
Elevance (ELV) and CVS Health (CVS) aren’t slouches, with ELV pushing “whole health” fluff while CVS owns Aetna and pharmacies galore. Fewer traders here, but one big fish stands out from October 2025 sales.
| Member | Chamber/Party/State | Stock | Approximate Value | Notes |
|---|---|---|---|---|
| Michael McCaul | House/R/TX | ELV | $15,001 – $50,000 | Sold October 27, 2025; prior holding implied. |
| Michael McCaul | House/R/TX | CVS | $15,001 – $50,000 | Sold October 27, 2025; prior holding implied. |
McCaul, a heavy hitter with over 1,200 trades lifetime, dumped these amid market dips. No buys offset, so he likely cleared out. For CI, HUM, CNC, MOH? Crickets in the filings—no direct trades or holdings popped in 2024-2025 reports.
The America First Fix: Ban the Trades, Drain the Swamp
This ain’t about party—Dems and Reps alike are in the trough, profiting while health costs crush families. America First means no more insider edges: slap a total ban on individual stock trades for members, spouses, and staff. Force real blind trusts, real-time disclosures, and jail time for cheats. Voters want it—80% in polls—but Congress stalls because they’re the crooks. With Trump back, push for reforms that gut these conflicts. No more letting pols vote billions to insurers then cash in. We’ve got the receipts; now let’s boot the bums. Your wallet—and the republic—depend on it.